Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$152.29

-3.27 (-2.10%)

16:21
08/08/17
08/08
16:21
08/08/17
16:21

Jazz Pharmaceuticals reports Q2 adjusted EPS $2.56, consensus $2.75

Reports Q2 revenue $394.39M, consensus $410.8M. Xyrem net product sales increased 6% in the second quarter of 2017 compared to the same period in 2016. Erwinaze/Erwinase net product sales in the second quarter of 2017 were consistent with net product sales in the same period in 2016.

  • 08

    Aug

JAZZ Jazz Pharmaceuticals
$152.29

-3.27 (-2.10%)

06/07/17
JPMS
06/07/17
NO CHANGE
JPMS
Overweight
Jazz Pharmaceuticals data beat investor expectations, says JPMorgan
JPMorgan analyst Jessica Fye believes full results from the Phase III JZP-110 narcolepsy and obstructive sleep apnea studies established a "compelling clinical profile" and beat investor expectations. JZP-110 represents a long-term growth driver outside of Xyrem, Fye tells investors in a research note. She believes the current valuation does not fully the double-digit growth she expects Jazz to generate over the next several years. The analyst reiterates an Overweight rating on the shares.
06/07/17
COWN
06/07/17
NO CHANGE
Target $190
COWN
Outperform
Cowen tells investors to be involved now in Jazz Pharmaceuticals
Cowen analyst Ken Cacciatore noted Jazz Pharmaceuticals presented positive Phase lll data on its drug candidate to treat daytime sleepiness and said the results were as good as could be hoped for. Given its efficacy/safety profile, he believes JZP-110 is "best-in-class" and likely a $750M product and recommends investors get involved now. Cacciatore reiterated his Outperform rating and $190 price target on Jazz Pharmaceuticals shares.
08/03/17
BMOC
08/03/17
NO CHANGE
BMOC
Outperform
Vyxeos label an 'upside suprise' for Jazz, says BMO Capital
BMO Capital analyst Gary Nachman said the FDA approval of Jazz Pharmaceuticals' Vyxeos for "poor-prognosis" AML patients came "on the earlier side of expectations" and with the "upside surprise" that there are no age restrictions in the label indication. The analyst, who said he is still bullish on the prospects for Vyxeos, keeps an Outperform rating on Jazz shares.
08/08/17
COWN
08/08/17
NO CHANGE
Target $190
COWN
Outperform
Jazz Pharmaceuticals assets undervalued, says Cowen
Cowen analyst Ken Cacciatore said Jazz Pharmaceuticals provided input from clinical consultants and its own commentary on Vyxeos, which increased conviction in the drug. Cacciatore, who believes the totality of its assets are undervalued, reiterated his Outperform rating and $190 price target on Jazz shares.

TODAY'S FREE FLY STORIES

VIOT

Viomi Technology

$0.00

(0.00%)

10:35
09/25/18
09/25
10:35
09/25/18
10:35
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FCAU

Fiat Chrysler

$18.22

-0.09 (-0.49%)

10:35
09/25/18
09/25
10:35
09/25/18
10:35
Options
Fiat Chrysler put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
09/25/18
09/25
10:35
09/25/18
10:35
General news
The U.S. consumer confidence »

The U.S. consumer…

CBM

Cambrex

$65.05

1.95 (3.09%)

10:31
09/25/18
09/25
10:31
09/25/18
10:31
Hot Stocks
Cambrex to expand, invest at High Point, North Carolina site »

Cambrex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VNTR

Venator Materials

$9.41

(0.00%)

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Downgrade
Venator Materials rating change  »

Venator Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
09/25/18
09/25
10:25
09/25/18
10:25
General news
U.S. Richmond Fed manufacturing index climbed 5 points to 29 in September »

U.S. Richmond Fed…

RHHBY

Roche

$0.00

(0.00%)

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Conference/Events
Roche to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Conference/Events
UBS waste market/recycling analyst to hold an analyst/industry conference call »

Analyst Windham, along…

VIOT

Viomi Technology

$0.00

(0.00%)

10:21
09/25/18
09/25
10:21
09/25/18
10:21
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FB

Facebook

$161.68

-3.72 (-2.25%)

10:20
09/25/18
09/25
10:20
09/25/18
10:20
Options
Heavy trading in Facebook as shares see relative weakness »

Heavy trading in Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 07

    Nov

10:20
09/25/18
09/25
10:20
09/25/18
10:20
General news
Treasury Action: yields remain below highs »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
09/25/18
09/25
10:17
09/25/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$220.79

(0.00%)

10:16
09/25/18
09/25
10:16
09/25/18
10:16
Periodicals
Apple still dealing with iPhone XR production issues, DigiTimes reports »

Apple has reportedly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/25/18
09/25
10:16
09/25/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$17.59

0.27 (1.56%)

, BJ

BJ's Wholesale

$27.30

-1.17 (-4.11%)

10:15
09/25/18
09/25
10:15
09/25/18
10:15
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

WEN

Wendy's

$17.59

0.27 (1.56%)

BJ

BJ's Wholesale

$27.30

-1.17 (-4.11%)

CENT

Central Garden & Pet

$38.28

(0.00%)

INSW

International Seaways

$20.57

0.63 (3.16%)

WELL

Welltower

$64.25

0.275 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 02

    Oct

  • 28

    Oct

  • 27

    Sep

INTC

Intel

$45.97

-0.94 (-2.00%)

, ON

ON Semiconductor

$18.54

-0.565 (-2.96%)

10:15
09/25/18
09/25
10:15
09/25/18
10:15
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

INTC

Intel

$45.97

-0.94 (-2.00%)

ON

ON Semiconductor

$18.54

-0.565 (-2.96%)

ADI

Analog Devices

$91.23

-3.78 (-3.98%)

DLTR

Dollar Tree

$84.38

-1.25 (-1.46%)

CY

Cypress Semiconductor

$14.53

-0.99 (-6.38%)

VALE

Vale

$14.88

0.085 (0.57%)

SBOW

SilverBow Resources

$28.70

-0.14 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 10

    Oct

  • 22

    Oct

  • 08

    May

CLX

Clorox

$150.49

0.51 (0.34%)

, DG

Dollar General

$107.69

0.4 (0.37%)

10:15
09/25/18
09/25
10:15
09/25/18
10:15
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

CLX

Clorox

$150.49

0.51 (0.34%)

DG

Dollar General

$107.69

0.4 (0.37%)

SAIC

SAIC

$80.82

1.94 (2.46%)

HP

Helmerich & Payne

$69.22

1.61 (2.38%)

CNI

Canadian National

$87.82

1 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

10:15
09/25/18
09/25
10:15
09/25/18
10:15
General news
U.S. consumer confidence rose 3.7 points to 138.4 in September »

U.S. consumer confidence…

10:15
09/25/18
09/25
10:15
09/25/18
10:15
General news
FX Action: The dollar »

FX Action: The dollar was…

IBM

IBM

$150.30

0.3 (0.20%)

, BABA

Alibaba

$164.77

1.63 (1.00%)

10:11
09/25/18
09/25
10:11
09/25/18
10:11
Periodicals
IBM's top cloud executive departs amid shakeup, The Information reports »

IBM's (IBM) top…

IBM

IBM

$150.30

0.3 (0.20%)

BABA

Alibaba

$164.77

1.63 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 22

    Oct

  • 28

    Oct

  • 03

    Mar

BA

Boeing

$369.73

1.69 (0.46%)

10:10
09/25/18
09/25
10:10
09/25/18
10:10
Options
Sweep buyers of Boeing weekly calls as shares advance »

Sweep buyers of Boeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIOT

Viomi Technology

$0.00

(0.00%)

10:10
09/25/18
09/25
10:10
09/25/18
10:10
Syndicate
Viomi Technology IPO indicated to open at $12 »

Viomi Technology priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AAPL

Apple

$220.57

-0.22 (-0.10%)

, AKAM

Akamai

$73.42

0.61 (0.84%)

10:07
09/25/18
09/25
10:07
09/25/18
10:07
Conference/Events
AT&T to hold a summit »

AT&T Business Summit…

AAPL

Apple

$220.57

-0.22 (-0.10%)

AKAM

Akamai

$73.42

0.61 (0.84%)

AMZN

Amazon.com

$1,947.50

13 (0.67%)

BB

BlackBerry

$10.57

0.14 (1.34%)

COF

Capital One

$96.99

-0.64 (-0.66%)

CSCO

Cisco

$48.62

0.17 (0.35%)

DE

Deere

$151.70

0.14 (0.09%)

ERIC

Ericsson

$9.08

0.115 (1.28%)

FORR

Forrester

$45.40

(0.00%)

FDX

FedEx

$242.02

-1.835 (-0.75%)

HON

Honeywell

$165.75

0.28 (0.17%)

GOOG

Alphabet

$1,177.22

3.84 (0.33%)

IBM

IBM

$150.20

0.2 (0.13%)

KO

Coca-Cola

$45.94

-0.135 (-0.29%)

TXN

Texas Instruments

$108.20

-1.61 (-1.47%)

SHLD

Sears

$1.21

-0.02 (-1.63%)

RHT

Red Hat

$136.00

1.13 (0.84%)

PANW

Palo Alto Networks

$232.50

1.91 (0.83%)

OMC

Omnicom

$70.09

-0.08 (-0.11%)

NOK

Nokia

$5.58

0.03 (0.54%)

MSFT

Microsoft

$114.68

-0.04 (-0.03%)

VMW

VMware

$154.53

1.04 (0.68%)

ZOOM

Zoom Technologies

$0.00

(0.00%)

ZS

Zscaler

$42.09

0.71 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 03

    Oct

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 19

    Oct

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

  • 13

    Nov

  • 28

    Nov

  • 06

    Dec

  • 10

    Dec

  • 03

    Mar

VUZI

Vuzix

$6.60

(0.00%)

10:06
09/25/18
09/25
10:06
09/25/18
10:06
Hot Stocks
Vuzix, 1Minuut partner to bring AR innovation through smart glasses »

Vuzix is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

GRUB

GrubHub

$138.36

3.57 (2.65%)

10:04
09/25/18
09/25
10:04
09/25/18
10:04
Recommendations
GrubHub analyst commentary  »

Stephens views Tapingo as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.